Table 5.

ROC analysis of Beclin 1 expression, EGFR and ALK mutations to predict postoperative PFS in non-squamous NSCLC patients

Variables	AUC	P	Cut-off value	Sensitivity (%)	Specificity (%)
Beclin 1	0.812	0.018	1.2	88.2	67.7
EGFR	0.781	0.011	15%	87.5	78.3
ALK	0.722	0.010	11%	89.2	80.1